Free Trial

Valhi (VHI) Competitors

Valhi logo
$15.87 -0.02 (-0.13%)
Closing price 04/15/2025 03:58 PM Eastern
Extended Trading
$15.86 -0.01 (-0.06%)
As of 04/15/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VHI vs. CC, PRM, BAK, UAN, PCT, NGVT, TROX, WLKP, ECVT, and OEC

Should you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), Perimeter Solutions (PRM), Braskem (BAK), CVR Partners (UAN), PureCycle Technologies (PCT), Ingevity (NGVT), Tronox (TROX), Westlake Chemical Partners (WLKP), Ecovyst (ECVT), and Orion (OEC). These companies are all part of the "chemicals" industry.

Valhi vs.

Chemours (NYSE:CC) and Valhi (NYSE:VHI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

In the previous week, Chemours had 20 more articles in the media than Valhi. MarketBeat recorded 21 mentions for Chemours and 1 mentions for Valhi. Chemours' average media sentiment score of 0.66 beat Valhi's score of 0.00 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive
Valhi
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Chemours currently has a consensus price target of $21.56, suggesting a potential upside of 93.76%. Valhi has a consensus price target of $20.00, suggesting a potential upside of 26.02%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Valhi.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
Valhi
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 9.0%. Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 2.0%. Chemours pays out 175.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Valhi pays out 8.5% of its earnings in the form of a dividend.

Valhi has lower revenue, but higher earnings than Chemours. Valhi is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.78B0.29-$238M$0.5719.52
Valhi$2.10B0.21-$12.10M$3.784.20

Chemours received 403 more outperform votes than Valhi when rated by MarketBeat users. However, 63.41% of users gave Valhi an outperform vote while only 60.67% of users gave Chemours an outperform vote.

CompanyUnderperformOutperform
ChemoursOutperform Votes
637
60.67%
Underperform Votes
413
39.33%
ValhiOutperform Votes
234
63.41%
Underperform Votes
135
36.59%

Chemours has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, Valhi has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

76.3% of Chemours shares are held by institutional investors. Comparatively, 3.8% of Valhi shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 0.1% of Valhi shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valhi has a net margin of 4.29% compared to Chemours' net margin of 1.51%. Chemours' return on equity of 26.54% beat Valhi's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours1.51% 26.54% 2.41%
Valhi 4.29%6.90%3.36%

Summary

Chemours beats Valhi on 14 of the 20 factors compared between the two stocks.

Remove Ads
Get Valhi News Delivered to You Automatically

Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VHI vs. The Competition

MetricValhiIndustrial inorganic chemicals IndustryMaterials SectorNYSE Exchange
Market Cap$449.04M$25.33B$2.96B$18.52B
Dividend Yield2.09%3.73%5.23%4.23%
P/E Ratio5.0911.0577.2031.15
Price / Sales0.212.6824,272,056,611,966,700.0025.69
Price / Cash12.6456.3524.3217.53
Price / Book0.368.575.194.29
Net Income-$12.10M$731.97M$154.96M$1.02B
7 Day Performance-3.26%-1.24%5.26%-0.79%
1 Month Performance-12.54%-12.68%2.39%-6.88%
1 Year Performance5.03%-24.93%15.94%1.74%

Valhi Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VHI
Valhi
2.8109 of 5 stars
$15.87
-0.1%
$20.00
+26.0%
+5.5%$449.04M$2.10B5.092,250News Coverage
Positive News
Gap Down
CC
Chemours
3.8871 of 5 stars
$11.55
+2.4%
$22.00
+90.5%
-57.3%$1.73B$5.78B20.266,600Analyst Forecast
Short Interest ↑
News Coverage
PRM
Perimeter Solutions
3.9252 of 5 stars
$9.99
+0.2%
$16.00
+60.2%
+39.6%$1.50B$560.97M-71.35240Positive News
Gap Down
BAK
Braskem
2.3108 of 5 stars
$3.49
+2.6%
$9.75
+179.4%
-63.0%$1.39B$77.41B-0.988,310News Coverage
UAN
CVR Partners
2.7921 of 5 stars
$72.35
+0.5%
N/A-6.6%$1.24B$525.32M12.56300Insider Trade
News Coverage
Positive News
PCT
PureCycle Technologies
2.5571 of 5 stars
$6.46
+3.7%
$12.50
+93.5%
+20.0%$1.16BN/A-4.31120News Coverage
Positive News
NGVT
Ingevity
2.5791 of 5 stars
$31.74
-0.7%
$53.83
+69.6%
-29.1%$1.16B$1.41B-2.682,050Analyst Downgrade
News Coverage
TROX
Tronox
4.3967 of 5 stars
$5.46
+4.4%
$12.93
+136.8%
-67.9%$862.34M$3.07B-17.616,610Analyst Forecast
WLKP
Westlake Chemical Partners
4.1308 of 5 stars
$22.36
-0.5%
N/A+4.3%$787.94M$1.14B12.78150News Coverage
Positive News
ECVT
Ecovyst
4.2256 of 5 stars
$5.91
+0.5%
$10.00
+69.2%
-41.1%$693.64M$704.49M12.85880
OEC
Orion
4.457 of 5 stars
$11.74
+0.4%
$22.00
+87.4%
-51.7%$665.12M$1.88B15.651,600News Coverage
Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NYSE:VHI) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners